GPC3 and neoplasm: Moving forward, combining GPC3-targeted MRI with therapy response biomarkers or imaging-guided biopsy could further enhance clinical decision-making by improving diagnostic accuracy and ensuring molecular characterization is obtained from the most relevant areas of the tumor.